Literature DB >> 25023876

Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma.

Alexandre Leon Ribeiro de Ávila1, Ana Cristina Victorino Krepischi, Luciana Facure Moredo, Talita Ferreira Marques Aguiar, Felipe Carneiro da Silva, Bianca Costa Soares de Sá, Amanda França de Nóbrega, Maria Isabel Waddington Achatz, João Pedreira Duprat, Gilles Landman, Dirce Maria Carraro.   

Abstract

Approximately 10 % of all cutaneous melanoma cases occur in a familial context. The major susceptibility gene for familial melanoma is CDKN2A. In Latin America, genetic studies investigating melanoma predisposition are scarce. The aim of this work was to investigate germline CDKN2A point mutations and genomic rearrangements in a cohort of 59 Brazilian melanoma-prone patients. Screening of CDKN2A alterations was performed by sequencing and multiplex ligation probe amplification. Germline CDKN2A mutations affecting p16(INK4a) were detected in 8 unrelated probands (13.6 %), including 7 familial cases and one patient with multiple melanomas; 4 out of 8 mutation carriers met the criteria for familial melanoma and had multiple primary lesions. Although this study adds to the literature on melanoma susceptibility in Latin America, it is limited by the small size of the cohort. Our findings suggest that stringent inclusion criteria led to a substantially increased rate of CDKN2A mutation detection. This consideration should be taken into account when referring patients for genetic screening in a setting of limited budget, such as in developing countries.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25023876     DOI: 10.1007/s10689-014-9736-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  29 in total

Review 1.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

2.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

3.  Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma.

Authors:  L Liu; D Dilworth; L Gao; J Monzon; A Summers; N Lassam; D Hogg
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

4.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

5.  Genetic variations of patients with familial or multiple melanoma in Southern Brazil.

Authors:  T C Grazziotin; M C W Rey; C G Bica; L A Pinto; R R Bonamigo; J A Puig-Butille; F Cuellar; S Puig
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-05-23       Impact factor: 6.166

Review 6.  Germline copy number variations and cancer predisposition.

Authors:  Ana Cristina Victorino Krepischi; Peter Lees Pearson; Carla Rosenberg
Journal:  Future Oncol       Date:  2012-04       Impact factor: 3.404

7.  Clinical and molecular characterization of patients at risk for hereditary melanoma in southern Brazil.

Authors:  Patricia Ashton-Prolla; Lucio Bakos; Gerson Junqueira; Roberto Giugliani; Sergio J Azevedo; David Hogg
Journal:  J Invest Dermatol       Date:  2007-08-23       Impact factor: 8.551

8.  The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma.

Authors:  J Huber; E S Ramos
Journal:  Braz J Med Biol Res       Date:  2006-02-02       Impact factor: 2.590

9.  CDKN2A mutations in melanoma families from Uruguay.

Authors:  A Larre Borges; A L Borges; F Cuéllar; J A Puig-Butillé; M Scarone; L Delgado; C Badenas; M Milà; J Malvehy; V Barquet; J Núñez; M Laporte; G Fernández; P Levrero; M Martínez-Asuaga; S Puig
Journal:  Br J Dermatol       Date:  2009-04-20       Impact factor: 9.302

10.  A novel SYBR-based duplex qPCR for the detection of gene dosage: detection of an APC large deletion in a familial adenomatous polyposis patient with an unusual phenotype.

Authors:  Giovana Tardin Torrezan; Felipe Cavalcanti Carneiro da Silva; Ana Cristina Victorino Krepischi; Erika Maria Monteiro dos Santos; Benedito Mauro Rossi; Dirce Maria Carraro
Journal:  BMC Med Genet       Date:  2012-07-16       Impact factor: 2.103

View more
  8 in total

Review 1.  Update in genetic susceptibility in melanoma.

Authors:  Miriam Potrony; Celia Badenas; Paula Aguilera; Joan Anton Puig-Butille; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Ann Transl Med       Date:  2015-09

2.  DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.

Authors:  Érica S S de Araújo; Dimitrius T Pramio; André Y Kashiwabara; Paula C Pennacchi; Silvya S Maria-Engler; Maria I Achatz; Antonio H J F M Campos; João P Duprat; Carla Rosenberg; Dirce M Carraro; Ana C V Krepischi
Journal:  Biomed Res Int       Date:  2015-04-12       Impact factor: 3.411

3.  Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.

Authors:  Susana Puig; Miriam Potrony; Francisco Cuellar; Joan Anton Puig-Butille; Cristina Carrera; Paula Aguilera; Eduardo Nagore; Zaida Garcia-Casado; Celia Requena; Rajiv Kumar; Gilles Landman; Bianca Costa Soares de Sá; Gisele Gargantini Rezze; Luciana Facure; Alexandre Leon Ribeiro de Avila; Maria Isabel Achatz; Dirce Maria Carraro; João Pedreira Duprat Neto; Thais C Grazziotin; Renan R Bonamigo; Maria Carolina W Rey; Claudia Balestrini; Enrique Morales; Montserrat Molgo; Renato Marchiori Bakos; Patricia Ashton-Prolla; Roberto Giugliani; Alejandra Larre Borges; Virginia Barquet; Javiera Pérez; Miguel Martínez; Horacio Cabo; Emilia Cohen Sabban; Clara Latorre; Blanca Carlos-Ortega; Julio C Salas-Alanis; Roger Gonzalez; Zulema Olazaran; Josep Malvehy; Celia Badenas
Journal:  Genet Med       Date:  2015-12-17       Impact factor: 8.822

4.  Multiple cutaneous melanomas associated with gastric and brain metastases.

Authors:  Lara Caroline Grander; Fernanda Cabral; Alice Paixão Lisboa; Gabrielle Vale; Carlos Baptista Barcaui; Juan Manuel Pineiro Maceira
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

5.  Hereditary melanoma: a five-year study of Brazilian patients in a cancer referral center - phenotypic characteristics of probands and pathological features of primary tumors.

Authors:  Bianca Costa Soares de Sá; Luciana Facure Moredo; Elimar Elias Gomes; Erica Sara Souza de Araújo; João Pedreira Duprat
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

6.  A Single Center Retrospective Review of Patients from Central Italy Tested for Melanoma Predisposition Genes.

Authors:  Paola De Simone; Irene Bottillo; Michele Valiante; Alessandra Iorio; Carmelilia De Bernardo; Silvia Majore; Daniela D'Angelantonio; Tiziana Valentini; Isabella Sperduti; Paolo Piemonte; Laura Eibenschutz; Angela Ferrari; Anna Carbone; Pierluigi Buccini; Alessandro Paiardini; Vitaliano Silipo; Pasquale Frascione; Paola Grammatico
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

7.  Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families.

Authors:  Felipe Fidalgo; Giovana Tardin Torrezan; Bianca Costa Soares de Sá; Bruna Durães de Figueiredo Barros; Luciana Facure Moredo; Renan Valieris; Sandro J de Souza; João Pereira Duprat; Ana Cristina Victorino Krepischi; Dirce Maria Carraro
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

8.  CDKN2A Polymorphism in Melanoma Patients in Colombian Population: A Case-Control Study.

Authors:  Jose D Tovar-Parra; Luz D Gutiérrez-Castañeda; Sebastián R Gil-Quiñones; Jhon A Nova; Leonardo Pulido
Journal:  Biomed Res Int       Date:  2020-10-10       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.